10-K Filing

ENVISION HEALTHCARE CORP CIK: 1344154 FY 2011

Filing Information

Form Type	10-K
Accession Number	`0001047469-12-002834`
Period End Date	20111231
Filing Date	20120316
Fiscal Year	2011
Fiscal Period	FY
XBRL Instance	ems-20111231.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 29 Income Statement 20 Cash Flow Statement 35 Stockholders Equity 13

Balance Sheet 29 line items

Line Item	Tag	Value	Unit	Period
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$286.55M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$134.02M	USD	Point-in-time
Insurance collateral	`RestrictedCashAndInvestmentsCurrent`	$40.84M	USD	Point-in-time
Trade and other accounts receivable, net	`AccountsReceivableNetCurrent`	$525.72M	USD	Point-in-time
Parts and supplies inventory	`InventoryNet`	$22.69M	USD	Point-in-time
Prepaids and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$26.18M	USD	Point-in-time
Current deferred tax assets	`DeferredTaxAssetsNetCurrent`	$24.23M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$773.68M	USD	Point-in-time
Property, plant and equipment, net	`PropertyPlantAndEquipmentNet`	$191.95M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$564.23M	USD	Point-in-time
Insurance collateral	`RestrictedCashAndInvestmentsNoncurrent`	$105.76M	USD	Point-in-time
Goodwill	`Goodwill`	$2.27B	USD	Point-in-time
Other long-term assets	`OtherAssetsNoncurrent`	$108.36M	USD	Point-in-time
Total assets	`Assets`	$4.01B	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$50.51M	USD	Point-in-time
Accrued liabilities	`AccruedLiabilitiesCurrent`	$323.25M	USD	Point-in-time
Current portion of long-term debt	`LongTermDebtCurrent`	$14.59M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$388.35M	USD	Point-in-time
Long-term debt	`LongTermDebtNoncurrent`	$2.36B	USD	Point-in-time
Long-term deferred tax liabilities	`DeferredTaxLiabilitiesNoncurrent`	$151.31M	USD	Point-in-time
Insurance reserves and other long-term liabilities	`InsuranceReservesAndOtherLongTermLiabilities`	$202.26M	USD	Point-in-time
Total liabilities	`Liabilities`	$3.10B	USD	Point-in-time
Preferred stock ($0.01 par value; 20,000,000 shares authorized in 2010, 0 issued and outstanding)	`PreferredStockValue`	-	USD	Point-in-time
Common stock	`CommonStockValue`	-	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$903.17M	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$13.02M	USD	Point-in-time
Accumulated other comprehensive (loss) income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-2.70M	USD	Point-in-time
Total equity	`StockholdersEquity`	$913.49M	USD	Point-in-time
Total liabilities and equity	`LiabilitiesAndStockholdersEquity`	$4.01B	USD	Point-in-time

Income Statement 20 line items

Line Item	Tag	Value	Unit	Period
Net revenue	`RevenueHealthCareOrganization`	$1.89B	USD	2 Qtrs
Compensation and benefits	`LaborAndRelatedExpense`	$1.31B	USD	2 Qtrs
Operating expenses	`OtherCostAndExpenseOperating`	$259.64M	USD	2 Qtrs
Insurance expense	`GeneralInsuranceExpense`	$65.03M	USD	2 Qtrs
Selling, general and administrative expenses	`OtherSellingGeneralAndAdministrativeExpense`	$44.35M	USD	2 Qtrs
Depreciation and amortization expense	`DepreciationAndAmortization`	$71.31M	USD	2 Qtrs
Restructuring charges	`RestructuringCharges`	$6.48M	USD	2 Qtrs
Income from operations	`OperatingIncomeLoss`	$127.93M	USD	2 Qtrs
Interest income from restricted assets	`InterestIncomeFromRestrictedAssets`	$1.95M	USD	2 Qtrs
Interest expense	`InterestExpense`	$104.70M	USD	2 Qtrs
Realized gain (loss) on investments	`GainLossOnSaleOfInvestments`	$41.00K	USD	2 Qtrs
Interest and other (expense) income	`OtherNonoperatingIncomeExpense`	$-3.15M	USD	2 Qtrs
Income before income taxes and equity in earnings of unconsolidated subsidiary	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$22.07M	USD	2 Qtrs
Income tax expense	`IncomeTaxExpenseBenefit`	$9.33M	USD	2 Qtrs
Income before equity in earnings of unconsolidated subsidiary	`IncomeLossBeforeEquityMethodInvestments`	$12.74M	USD	2 Qtrs
Equity in earnings of unconsolidated subsidiary	`IncomeLossFromEquityMethodInvestments`	$276.00K	USD	2 Qtrs
Net income	`NetIncomeLoss`	$13.02M	USD	2 Qtrs
Unrealized holding (losses) gains during the period	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-41.00K	USD	2 Qtrs
Unrealized (losses) gains on derivative financial instruments	`OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax`	$-2.66M	USD	2 Qtrs
Comprehensive income	`ComprehensiveIncomeNetOfTax`	$10.32M	USD	2 Qtrs

Cash Flow Statement 35 line items

Line Item	Tag	Value	Unit	Period
Net income	`NetIncomeLoss`	$13.02M	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$81.54M	USD	2 Qtrs
Loss on disposal of property, plant and equipment	`GainLossOnSaleOfPropertyPlantEquipment`	$-156.00K	USD	2 Qtrs
Equity-based compensation expense	`ShareBasedCompensation`	$4.10M	USD	2 Qtrs
Equity in earnings of unconsolidated subsidiary	`IncomeLossFromEquityMethodInvestments`	$276.00K	USD	2 Qtrs
Deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$-4.13M	USD	2 Qtrs
Trade and other accounts receivable	`IncreaseDecreaseInAccountsAndOtherReceivables`	$4.73M	USD	2 Qtrs
Parts and supplies inventory	`IncreaseDecreaseInInventories`	$-884.00K	USD	2 Qtrs
Prepaids and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-641.00K	USD	2 Qtrs
Accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$7.02M	USD	2 Qtrs
Insurance accruals	`IncreaseDecreaseInAccruedInsurance`	$16.60M	USD	2 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$114.82M	USD	2 Qtrs
Merger, net of cash received	`PaymentsToMergeBusinessesNetOfCashAcquired`	$-2.84B	USD	2 Qtrs
Purchases of property, plant and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$46.35M	USD	2 Qtrs
Proceeds from sale of property, plant and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$216.00K	USD	2 Qtrs
Acquisition of businesses, net of cash received	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$84.38M	USD	2 Qtrs
Net change in insurance collateral	`NetChangeInInsuranceCollateral`	$9.93M	USD	2 Qtrs
Other investing activities	`PaymentsForProceedsFromOtherInvestingActivities`	$1.17M	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-2.97B	USD	2 Qtrs
Borrowings under senior secured credit facility	`ProceedsFromIssuanceOfSeniorLongTermDebt`	$1.44B	USD	2 Qtrs
Proceeds from issuance of senior subordinated notes	`ProceedsFromIssuanceOfSubordinatedLongTermDebt`	$950.00M	USD	2 Qtrs
Proceeds from CD&R equity investment	`ProceedsFromInvestmentsMadeByParent`	$887.05M	USD	2 Qtrs
Capital contributions	`ProceedsFromContributedCapital`	$4.98M	USD	2 Qtrs
Repayments of capital lease obligations and other debt	`RepaymentsOfLongTermDebtAndCapitalSecurities`	$426.77M	USD	2 Qtrs
Equity issuance costs	`PaymentsOfStockIssuanceCosts`	$31.88M	USD	2 Qtrs
Debt issue costs	`PaymentsOfDebtIssuanceCosts`	$117.81M	USD	2 Qtrs
Net change in bank overdrafts	`ProceedsFromRepaymentsOfBankOverdrafts`	$-6.94M	USD	2 Qtrs
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$2.70B	USD	2 Qtrs
Change in cash and cash equivalents	`NetCashProvidedByUsedInContinuingOperations`	$-152.53M	USD	2 Qtrs
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$286.55M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$134.02M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$286.55M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$134.02M	USD	Point-in-time
Cash paid for interest	`InterestPaidNet`	$83.92M	USD	2 Qtrs
Cash paid (refunds received) for taxes	`IncomeTaxesPaidNet`	$9.54M	USD	2 Qtrs

Stockholders Equity 13 line items

Line Item	Tag	Value	Unit	Period
Investment by Parent, issuance costs	`AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts`	$31.88M	USD	2 Qtrs
Beginning balance	`StockholdersEquity`	$913.49M	USD	Point-in-time
Investment by Parent, net of issuance costs of $31,878	`InvestmentByParentNetOfIssuanceCosts`	$855.17M	USD	2 Qtrs
Tax effect of equity issuance costs	`AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet`	$6.66M	USD	2 Qtrs
Investment by management	`InvestmentByManagement`	$4.98M	USD	2 Qtrs
Management equity rollover	`ManagementEquityRollover`	$28.27M	USD	2 Qtrs
Equity-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$4.10M	USD	2 Qtrs
Equity issued for acquisition	`StockIssuedDuringPeriodValueAcquisitions`	$4.00M	USD	2 Qtrs
Net income	`NetIncomeLoss`	$13.02M	USD	2 Qtrs
Fair value of fuel hedge	`FairValueOfFuelHedge`	$1.20M	USD	2 Qtrs
Net change in fair value of interest rate swap agreement	`OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent`	$-1.46M	USD	2 Qtrs
Unrealized holding gains (losses)	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-41.00K	USD	2 Qtrs
Ending balance	`StockholdersEquity`	$913.49M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.